Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

69.85
Delayed Data
As of Feb 17
 -0.46 / -0.65%
Today’s Change
65.38
Today|||52-Week Range
103.10
-2.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line3.1B12.1B18.1B--
 
 
 
 
Depreciation344.7M1.1B1.1B--
 
 
 
 
Total Other Cash Flow363.9M463.0M355.0M--
 
 
 
 
Funds From Operations3.7B13.3B19.2B--
 
 
 
 
Funds From/For Other Operating Expenses562.7M518.0M-1.2B--
 
 
 
 
Net Cash Flow - Operating Activities3.1B12.8B20.3B--
 
 
 
 
 
InvestingIncrease In Investments-256.7M-2.1B-17.2B--
 
 
 
 
Decrease In Investments571.8M859.0M5.5B--
 
 
 
 
Capital Expenditures-190.8M-557.0M-747.0M--
 
 
 
 
Net Assets From Acquisitions -378.6M0.000.00--
 
 
Net Cash Flow Investing-254.4M-1.8B-12.5B--
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings2.8B10.5B10.7B--
 
 
 
 
Long Term Debt Reduction-5.5B-4.8B-997.0M--
 
 
 
 
Net Proceeds Stock Sale313.1M331.0M319.0M--
 
 
 
 
Common Preferred Redeemed-582.4M-5.3B-10.0B--
 
 
 
 
Common Dividends0.000.00-1.9B--
 
 
Cash Dividends Paid - Total0.000.00-1.9B--
 
 
Other Sources - Financing430.6M517.0M773.0M--
 
 
 
 
Other Uses - Financing77.0K4.2B3.9B--
 
 
 
 
Net Cash Flow - Financing-2.5B-3.0B-5.0B--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash2.4M-56.0M-67.0M--
 
 
 
 
 
Net Change In Cash306.7M8.0B2.9B0.00